BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 30, 1999
View Archived Issues
Quetiapine as a treatment for drug-induced psychosis in PD
Read More
Trimeris initiates patient selection and dosing in T-20 phase II trial
Read More
FDA approves 15-mg Ditropan XL tablets
Read More
QLT terminates collaboration with Beaufour Ipsen
Read More
ICAgen licenses novel ion channel genes from SUNY
Read More
New hepatitis A vaccine affords protection with first dose
Read More
Shire reports positive phase II results for Lambda
Read More
FeRx's targeted carrier tested in doxorubicin delivery to liver cancer patients
Read More
Ziagen approved in Canada in combination therapy for HIV/AIDS therapy
Read More
BMS withdraws from brasofensine collaboration with NeuroSearch
Read More
Lundbeck develops radiolabeled 5-HT2 receptor antagonist for PET studies
Read More
Enzon and Schering-Plough revise agreement for PEG-Intron
Read More
InKine's CBP-1011 to continue phase III development
Read More
Genentech submits NDA to FDA for Nutropin Depot
Read More
Multifunctional antiinflammatory agents in development at ADIR
Read More
New benzothiophene ET antagonists from Pfizer
Read More
Shiseido describes new gastric antisecretory agents for ulcers
Read More
Orphanin FQ receptor ligands designed at Roche for therapeutic use
Read More
Lilly patents new series of selective beta3-agonists for diabetes, obesity
Read More
New compounds from Merck inhibit posttranslational farnesylation of proteins
Read More
Piperidines synthesized at Toa Eiyo act as 5-HT2 antagonists and antiplatelet agents
Read More
Australian team presents in vivo results with new, orally active C5a receptor antagonist
Read More
Dusa receives FDA approvable letter for Levulan NDA
Read More
Aronex reports responses in phase II trial of Atragen as treatment of NHL
Read More
Merckle cPLA2 inhibitor demonstrates both acute antiinflammatory and antiasthmatic effects
Read More
SmithKline Beecham launches new combined vaccine for hepatitis A and typhoid in the U.K.
Read More
R-146225: orally active inhibitor of both IL-5 protein and mRNA production
Read More
Xoma licenses use of recombinant BPI to Allergan for ophthalmic infections
Read More
Nitroderivative of aspirin endowed with significant myocardial protective effects
Read More
